Search

everythinglearnresearchcommunity

for

Search:↓

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Flutamide rarely causes liver toxicity in prostate cancer patients.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride does not prevent bladder cancer.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

No link was found between hair patterns and prostate cancer risk in South Indian men.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Finasteride treats hair loss but may affect prostate cancer detection.

Certain natural compounds called terpenes may help prevent prostate cancer.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Certain genetic markers may increase or decrease prostate cancer risk.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.